none
none

US PATENT RECOGNISES AUSSIE WASTEWATER TECHNOLOGIES

28-09-2017
by 
in 
Relocatable processing plant

Queensland based Hydrus Technology has received a US patent for its advanced electrochemical and catalytically enhanced oxidation wastewater technologies.

The two technologies allow the company’s relocatable processing plant to turn contaminated water and wastewater into water ready for reuse or safe release into the environment. Importantly, the treated wastewater meets typical Environmental Protection Agency (EPA) standards and typical client-specified water quality targets.

“We have developed game changing technology that provides customised solutions in the oil and gas, mining and industrial sectors,” says David Cam, CEO of Hydrus Technology. “Now we’re expanding our first-class technology and strong R&D efforts into other vertical markets, targeting high value solutions to challenging wastewater problems.”

Hydrus Technology
07 3390 4592
hydrustech.com

 

Related news & editorials

  1. Adaptalift acquires Budget
    11.12.2017
    11.12.2017
    by      In
    Adaptalift Group has completed its acquisition of Budget Forklifts.
    Budget Forklifts was established in 1968 and is the Yale Dealer in Western Australia and Queensland. Adaptalift Group will continue to operate Budget Forklifts as the Yale dealership in those territories.
    Budget Forklifts has more... Read More
  2. 07.12.2017
    07.12.2017
    by      In
    It’s official: Industry Update is on the rise. The November 2017 issue of the magazine was distributed to 19,030 subscribers – a figure confirmed by an independent auditors’ report to the Audited Media Association of Australia (AMAA).
    The figure, which corresponds to a circulation in excess of 76,... Read More
  3. 07.12.2017
    07.12.2017
    by      In
    Amidst a barrage of complaints from consumers and companies alike, NBN Co has announced that it will cease selling services on its hybrid fibre-coaxial (HFC) network.
    This temporary halt in rollout is due to "interference" from Telstra's infrastructure, which was leading to dropouts and... Read More
  4. 07.12.2017
    07.12.2017
    by      In
    Just one year ago pain med brand Nurofen was slugged with a $6 million dollar fine for making false claims about pain relief; now Voltaren is under fire for the exact same issue.
    The ACCC has filed formal proceedings in the Federal Court against GlaxoSmithKline and Novartis, alleging the drugmakers... Read More